Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0042592
|
homeostatic process |
P2RX7,IGF2,EGR2,VEGFA,EP300,CXCR4,DKC1,CASP3,TP53, |
7.51E-7 |
GO:0042110
|
T cell activation |
P2RX7,IGF2,CXCR4,FLT3,TP53, |
1.19E-5 |
GO:0010604
|
positive regulation of macromolecule metabolic process |
P2RX7,IGF2,EGR2,VEGFA,EP300,ZEB1,TP53,AKT2, |
2.75E-5 |
GO:0010557
|
positive regulation of macromolecule biosynthetic process |
IGF2,EGR2,VEGFA,EP300,ZEB1,TP53,AKT2, |
6.58E-5 |
GO:0046649
|
lymphocyte activation |
P2RX7,IGF2,CXCR4,FLT3,TP53, |
7.19E-5 |
|
GO:0031328
|
positive regulation of cellular biosynthetic process |
IGF2,EGR2,VEGFA,EP300,ZEB1,TP53,AKT2, |
8.52E-5 |
GO:0009891
|
positive regulation of biosynthetic process |
IGF2,EGR2,VEGFA,EP300,ZEB1,TP53,AKT2, |
9.24E-5 |
GO:0008283
|
cell proliferation |
P2RX7,VEGFA,CXCR4,DKC1,ZEB1,TP53, |
1.10E-4 |
GO:0045321
|
leukocyte activation |
P2RX7,IGF2,CXCR4,FLT3,TP53, |
1.53E-4 |
GO:0007389
|
pattern specification process |
EGR2,VEGFA,EP300,CXCR4,ZEB1, |
2.23E-4 |
GO:0048878
|
chemical homeostasis |
P2RX7,IGF2,EGR2,VEGFA,CXCR4,TP53, |
2.35E-4 |
GO:0001775
|
cell activation |
P2RX7,IGF2,CXCR4,FLT3,TP53, |
2.95E-4 |
GO:0042098
|
T cell proliferation |
P2RX7,CXCR4,TP53, |
4.52E-4 |
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
IGF2,EGR2,VEGFA,EP300,ZEB1,TP53, |
5.86E-4 |
GO:0051173
|
positive regulation of nitrogen compound metabolic process |
IGF2,EGR2,VEGFA,EP300,ZEB1,TP53, |
6.78E-4 |
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter |
EGR2,VEGFA,EP300,ZEB1,TP53, |
7.79E-4 |
GO:0046651
|
lymphocyte proliferation |
P2RX7,CXCR4,TP53, |
1.09E-2 |
GO:0008219
|
cell death |
P2RX7,IGF2,EP300,CXCR4,CASP3,TP53, |
1.11E-2 |
GO:0010033
|
response to organic substance |
P2RX7,IGF2,EGR2,EP300,CASP3,AKT2, |
1.13E-2 |
GO:0016265
|
death |
P2RX7,IGF2,EP300,CXCR4,CASP3,TP53, |
1.15E-2 |
GO:0032943
|
mononuclear cell proliferation |
P2RX7,CXCR4,TP53, |
1.20E-2 |
GO:0070661
|
leukocyte proliferation |
P2RX7,CXCR4,TP53, |
1.20E-2 |
GO:0030182
|
neuron differentiation |
PTPRR,EGR2,NOTCH3,VEGFA,CXCR4, |
1.44E-2 |
GO:0042127
|
regulation of cell proliferation |
IGF2,VEGFA,FLT3,ZEB1,CASP3,TP53, |
1.67E-2 |
GO:0045596
|
negative regulation of cell differentiation |
NOTCH3,FLT3,ZEB1,TP53, |
1.92E-2 |
GO:0045893
|
positive regulation of transcription, DNA-dependent |
EGR2,VEGFA,EP300,ZEB1,TP53, |
1.98E-2 |
GO:0051254
|
positive regulation of RNA metabolic process |
EGR2,VEGFA,EP300,ZEB1,TP53, |
2.04E-2 |
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway |
IGF2,VEGFA,FLT3,AKT2, |
2.13E-2 |
GO:0009611
|
response to wounding |
P2RX7,IGF2,NOTCH3,CXCR4,CASP3, |
2.91E-2 |
GO:0045941
|
positive regulation of transcription |
EGR2,VEGFA,EP300,ZEB1,TP53, |
3.64E-2 |
GO:0010628
|
positive regulation of gene expression |
EGR2,VEGFA,EP300,ZEB1,TP53, |
4.05E-2 |
GO:0044093
|
positive regulation of molecular function |
P2RX7,IGF2,EP300,CXCR4,TP53, |
4.18E-2 |
GO:0002683
|
negative regulation of immune system process |
IGF2,FLT3,CASP3, |
4.22E-2 |
GO:0032868
|
response to insulin stimulus |
IGF2,EGR2,AKT2, |
6.06E-2 |
GO:0048872
|
homeostasis of number of cells |
P2RX7,VEGFA,CASP3, |
6.06E-2 |
GO:0043009
|
chordate embryonic development |
PTPRR,EP300,ZEB1,TP53, |
6.41E-2 |
GO:0009792
|
embryonic development ending in birth or egg hatching |
PTPRR,EP300,ZEB1,TP53, |
6.57E-2 |
GO:0060249
|
anatomical structure homeostasis |
P2RX7,VEGFA,DKC1, |
6.79E-2 |
GO:0007167
|
enzyme linked receptor protein signaling pathway |
IGF2,VEGFA,FLT3,AKT2, |
7.02E-2 |
GO:0043408
|
regulation of MAPKKK cascade |
P2RX7,IGF2,AKT2, |
7.17E-2 |
GO:0045859
|
regulation of protein kinase activity |
P2RX7,IGF2,CXCR4,CASP3, |
7.19E-2 |
GO:0043066
|
negative regulation of apoptosis |
IGF2,VEGFA,CASP3,TP53, |
7.72E-2 |
GO:0043549
|
regulation of kinase activity |
P2RX7,IGF2,CXCR4,CASP3, |
7.90E-2 |
GO:0043069
|
negative regulation of programmed cell death |
IGF2,VEGFA,CASP3,TP53, |
8.02E-2 |
GO:0060548
|
negative regulation of cell death |
IGF2,VEGFA,CASP3,TP53, |
8.08E-2 |
GO:0008285
|
negative regulation of cell proliferation |
FLT3,ZEB1,CASP3,TP53, |
8.15E-2 |
GO:0009725
|
response to hormone stimulus |
IGF2,EGR2,EP300,AKT2, |
8.52E-2 |
GO:0051338
|
regulation of transferase activity |
P2RX7,IGF2,CXCR4,CASP3, |
8.84E-2 |
GO:0006357
|
regulation of transcription from RNA polymerase II promoter |
EGR2,VEGFA,EP300,ZEB1,TP53, |
8.96E-2 |
GO:0006873
|
cellular ion homeostasis |
P2RX7,EGR2,CXCR4,TP53, |
8.98E-2 |
GO:0055082
|
cellular chemical homeostasis |
P2RX7,EGR2,CXCR4,TP53, |
9.38E-2 |
GO:0045779
|
negative regulation of bone resorption |
P2RX7,VEGFA, |
9.42E-2 |
GO:0046851
|
negative regulation of bone remodeling |
P2RX7,VEGFA, |
9.42E-2 |
|
|
|
|
|
|